FDA warns J&J unit over device marketing

08/24/2010 | Los Angeles Times (tiered subscription model)

The FDA issued a warning letter to DePuy Orthopaedics saying that the Johnson & Johnson unit is selling an unapproved device, the TruMatch Personalized Solution System, and marketing another device, the Corail Hip System, for off-label uses. A DePuy statement said the company is "reviewing the letter to understand the FDA's concerns and will respond to their request for information."

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL